Furthermore, mTOR inhibitors exhibit the ability to suppress tumor angiogenesis by targeting the vascular endothelial growth factor (VEGF) pathway, ultimately leading to decreased tumor growth and invasion. The gene discussed is MTOR; the disease is neoplasm.